{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:28Z","timestamp":1790975128714,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006485","name":"National Institute for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["4003355"],"award-info":[{"award-number":["4003355"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijbiomac.2026.150913","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:14:44Z","timestamp":1771226084000},"page":"150913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design and structural characterization of a chimeric protein displayed on virus-like particles for targeted immune activation against Salmonella Typhi"],"prefix":"10.1016","volume":"350","author":[{"given":"Saghi","family":"Nooraei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hajizade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Tarrahimofrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmoein","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shamsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150913_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.imlet.2017.07.006","article-title":"Salmonella infection: interplay between the bacteria and host immune system","volume":"190","author":"Kurtz","year":"2017","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150913_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JB.185.2.553-563.2003","article-title":"Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S. enterica serovar Typhimurium DNA microarray","volume":"185","author":"Chan","year":"2003","journal-title":"J. Bacteriol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150913_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002191","article-title":"Salmonella bongori provides insights into the evolution of the salmonellae","volume":"7","author":"Fookes","year":"2011","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150913_bb0025","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1128\/JCM.43.8.3688-3698.2005","article-title":"DNA sequence-based subtyping and evolutionary analysis of selected Salmonella enterica serotypes","volume":"43","author":"Sukhnanand","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-020-14655-9","article-title":"Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface","volume":"11","author":"Dom\u00ednguez-Medina","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150913_bb0035","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.vaccine.2014.11.012","article-title":"Development of a Salmonella cross-protective vaccine for food animal production systems","volume":"33","author":"Heithoff","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150913_bb0045","first-page":"305","article-title":"Updated recommendations for the use of typhoid vaccine\u2014advisory committee on immunization practices, United States, 2015","volume":"64","author":"Jackson","year":"2015","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0050","series-title":"Seminars in Immunology","article-title":"Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines","year":"2017"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150913_bb0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/1574-6968.12013","article-title":"Immunogenic characterization of outer membrane porins OmpC and OmpF of porcine extraintestinal pathogenic Escherichia coli","volume":"337","author":"Liu","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150913_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158894","article-title":"Distinctive recognition of flagellin by human and mouse toll-like receptor 5","volume":"11","author":"Forstneri\u010d","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150913_bb0065","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1074\/jbc.M307759200","article-title":"Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro","volume":"279","author":"Murthy","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/btm2.10049","article-title":"Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery","volume":"2","author":"Rohovie","year":"2017","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0075","article-title":"In silico design and immunoinformatics analysis of a chimeric vaccine construct based on Salmonella pathogenesis factors","volume":"180","author":"Abadi","year":"2023","journal-title":"Microb. Pathog."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150913_bb0080","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150913_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150913_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0095","article-title":"Designing and bioinformatic analysis of immunogenic recombinant chimeric protein containing rSEB and CTB for vaccine","volume":"13","author":"Ahmadi","year":"2021","journal-title":"International Journal of Pharmaceutical Research"},{"issue":"suppl_2","key":"10.1016\/j.ijbiomac.2026.150913_bb0100","article-title":"Algpred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0110","series-title":"Computational Peptidology","first-page":"143","article-title":"Peptide toxicity prediction","author":"Gupta","year":"2015"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0115","first-page":"13","article-title":"Analysis to describe the catalytic critical residue of keratinase mojavensis using peptidase inhibitors: a docking-based bioinformatics study","volume":"7","author":"Rahimnahal","year":"2020","journal-title":"J Bas Res Med Sci."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105837","article-title":"Development of a chimeric vaccine candidate based on toxoplasma gondii major surface antigen 1 and apicoplast proteins using comprehensive immunoinformatics approaches","volume":"162","author":"Asghari","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.150913_bb0125","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150913_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jsb.2011.12.002","article-title":"Toll-like receptor 5 forms asymmetric dimers in the absence of flagellin","volume":"177","author":"Zhou","year":"2012","journal-title":"J. Struct. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150913_bb0135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2. 2 web server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"Van Zundert","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150913_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009809","article-title":"Versatile virus-like particle carrier for epitope based vaccines","volume":"5","author":"Tissot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0145","series-title":"Microbial Production of High-Value Products","first-page":"271","article-title":"Bioengineering and bioprocessing of virus-like particle vaccines in Escherichia coli","author":"Abidin","year":"2022"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150913_bb0150","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3748\/wjg.v12.i6.921","article-title":"Expression, purification and characterization of enterovirus-71 virus-like particles","volume":"12","author":"Chung","year":"2006","journal-title":"World J Gastroenterol: WJG"},{"issue":"sup3","key":"10.1016\/j.ijbiomac.2026.150913_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/21691401.2018.1529676","article-title":"EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7","volume":"46","author":"Hajizade","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150913_bb0160","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0165","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/btm2.10049","article-title":"Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery","volume":"2","author":"Rohovie","year":"2017","journal-title":"Bioeng. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150913_bb0175","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm. Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.150913_bb0180","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.3390\/ijms23158579","article-title":"Virus-like particles: fundamentals and biomedical applications","volume":"23","author":"Mej\u00eda-M\u00e9ndez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ultramic.2017.07.001","article-title":"A direct comparison of experimental methods to measure dimensions of synthetic nanoparticles","volume":"182","author":"Eaton","year":"2017","journal-title":"Ultramicroscopy"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-016-0181-1","article-title":"Bacterial superglue enables easy development of efficient virus-like particle based vaccines","volume":"14","author":"Thrane","year":"2016","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/srep19234","article-title":"Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150913_bb0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/vaccines8010128","article-title":"Better adjuvants for better vaccines: Progress in adjuvant delivery systems, modifications, and adjuvant\u2013antigen codelivery","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100103","article-title":"Overview of vaccine adjuvants","volume":"11","author":"Wu","year":"2021","journal-title":"Medicine in Drug Discovery."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01100","article-title":"Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): toward better engineering of VLPs","volume":"11","author":"Zepeda-Cervantes","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1065609","article-title":"Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates","volume":"14","author":"Collett","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112316","article-title":"Mesoporous silica nanoparticles-based formulations of a chimeric proteinous vaccine candidate against necrotic enteritis disease","volume":"128","author":"Hoseini","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"issue":"45","key":"10.1016\/j.ijbiomac.2026.150913_bb0230","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1016\/j.vaccine.2020.08.074","article-title":"rOmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00230","article-title":"Salmonella Typhi porins OmpC and OmpF are potent adjuvants for T-dependent and T-independent antigens","volume":"8","author":"P\u00e9rez-Toledo","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150913_bb0240","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4049\/jimmunol.1301893","article-title":"Flagellin induces antibody responses through a TLR5-and inflammasome-independent pathway","volume":"192","author":"L\u00f3pez-Yglesias","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2180-4-33","article-title":"Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-\u03baB and proinflammatory gene program activation in intestinal epithelial cells","volume":"4","author":"Tallant","year":"2004","journal-title":"BMC Microbiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150913_bb0250","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4049\/jimmunol.1301893","article-title":"Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway","volume":"192","author":"L\u00f3pez-Yglesias","year":"2014","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/protein\/10.9.999","article-title":"Hydrogen bonds and salt bridges across protein-protein interfaces","volume":"10","author":"Xu","year":"1997","journal-title":"Protein Eng. Des. Sel."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137113","article-title":"Exploring Strong interactions in proteins with quantum chemistry and examples of their applications in drug design","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150913_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006574","article-title":"The role of the C-terminal D0 domain of flagellin in activation of toll like receptor 5","volume":"13","author":"Forstneri\u010d","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01523","article-title":"Toll-like receptors, associated biological roles, and signaling networks in non-mammals","volume":"9","author":"Nie","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin\u2014a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150913_bb0280","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1128\/JB.00094-06","article-title":"Transcriptional and translational control of the Salmonella fliC gene","volume":"188","author":"Aldridge","year":"2006","journal-title":"J. Bacteriol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150913_bb0285","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pep.2008.04.013","article-title":"Increasing the homogeneity, stability and activity of human serum albumin and interferon-\u03b12b fusion protein by linker engineering","volume":"61","author":"Zhao","year":"2008","journal-title":"Protein Expr. Purif."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0952-7915(01)00293-X","article-title":"A closer look at proteolysis and MHC-class-II-restricted antigen presentation","volume":"14","author":"Lennon-Dum\u00e9nil","year":"2002","journal-title":"Curr. Opin. Immunol."},{"issue":"17\u201318","key":"10.1016\/j.ijbiomac.2026.150913_bb0300","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","article-title":"An ingenious design for peptide vaccines","volume":"23","author":"Yano","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150913_bb0305","first-page":"125","article-title":"Nanoparticles in vaccine development","volume":"1","author":"Hajizade","year":"2014","journal-title":"Journal of Applied Biotechnology Reports."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150913_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11071172","article-title":"Nanoparticle-based adjuvants and delivery systems for modern vaccines","volume":"11","author":"Filipi\u0107","year":"2023","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150913_bb0315","first-page":"517","article-title":"An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coli","volume":"21","author":"Kordbacheh","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0320","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molimm.2019.09.015","article-title":"Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. Coli O157: H7","volume":"114","author":"Kordbacheh","year":"2019","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150913_bb0325","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/nnm-2020-0358","article-title":"A meta-analysis of the efficiency of metal nanoparticles in vaccine delivery against infectious disease","volume":"16","author":"Hoseini","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0330","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2017.00239","article-title":"Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development","volume":"8","author":"Marques Neto","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150913_bb0335","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/acsabm.3c00843","article-title":"Lipid-and polymer-based nanocarrier platforms for cancer vaccine delivery","volume":"7","author":"Sunoqrot","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150913_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040403","article-title":"AP205 VLPs based on dimerized capsid proteins accommodate RBM domain of SARS-CoV-2 and serve as an attractive vaccine candidate","volume":"9","author":"Liu","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0345","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3389\/fimmu.2020.01100","article-title":"Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): toward better engineering of VLPs","volume":"11","author":"Zepeda-Cervantes","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150913_bb0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12951-022-01710-4","article-title":"A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150913_bb0355","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1708-8305.2009.00351.x","article-title":"Virosomal hepatitis a vaccine: comparing intradermal and subcutaneous with intramuscular administration","volume":"16","author":"Fr\u00f6sner","year":"2009","journal-title":"J. Travel Med."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150913_bb0365","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1473-3099(12)70029-4","article-title":"Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?","volume":"12","author":"Patel","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0370","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40620-019-00668-1","article-title":"Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis","volume":"33","author":"Udomkarnjananun","year":"2020","journal-title":"J. Nephrol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12267","article-title":"Extracellular vesicles elicit protective immune responses against Salmonella infection","volume":"11","author":"Emerson","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150913_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9080845","article-title":"T-cell cytokine response in Salmonella typhimurium-vaccinated versus infected pigs","volume":"9","author":"Schmidt","year":"2021","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185488","article-title":"A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges","volume":"12","author":"Vinod","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150913_bb0390","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/v15051109","article-title":"Virus-like particle vaccines and platforms for vaccine development","volume":"15","author":"Kheirvari","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2026.150913_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123805","article-title":"Platforms, advances, and technical challenges in virus-like particles-based vaccines","volume":"14","author":"Gupta","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150913_bb0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026008391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026008391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:00:21Z","timestamp":1775102421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026008391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":80,"alternative-id":["S0141813026008391"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150913","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and structural characterization of a chimeric protein displayed on virus-like particles for targeted immune activation against Salmonella Typhi","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150913"}}